PLK1 and non-small cell lung carcinoma: Analogous to a report from Wang et al. [15], their research showed that PLK1 overexpression was markedly associated with advanced clinical stage, higher tumor classification, and lymph node metastasis in non-small cell lung cancer patients [15].